FDA Approved: SPIRONOLACTONE — Original Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA approved the original ANDA for spironolactone, authorizing a generic version manufactured by Jubilant Cadista Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis with Ascites
• Edema
• Heart Failure
• Hyperaldosteronism
• Hypertension
• Nephrotic Syndrome

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

ORIG AP for SPIRONOLACTONE (SPIRONOLACTONE)